Normalizing metabolism in diabetic pregnancy: Is it time to target lipids?

Diabetes Care

Volumn 37, Issue 5, 2014, Pages 1484-1493

  Barrett, Helen L ^a,b,c   Nitert, Marloes Dekker ^a,c   McIntyre, H David ^c,d   Callaway, Leonie K ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NICOTINIC ACID; PRAVASTATIN; RESVERATROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; LIPOPROTEIN;

ADVERSE OUTCOME; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DISEASE ASSOCIATION; DYSLIPIDEMIA; EXERCISE; FETUS CIRCULATION; GLYCEMIC CONTROL; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; MATERNAL OBESITY; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUPPLEMENTATION; SYSTEMATIC REVIEW (TOPIC); ADULT; COMPLICATION; DIABETES, GESTATIONAL; DRUG EFFECTS; DYSLIPIDEMIAS; FEMALE; FETOMATERNAL TRANSFUSION; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HYPERLIPOPROTEINEMIA TYPE IV; METABOLISM; NEWBORN; OBESITY; PREGNANCY; PREGNANCY IN DIABETICS;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DYSLIPIDEMIAS; FEMALE; GESTATIONAL AGE; HUMANS; HYPERLIPOPROTEINEMIA TYPE IV; INFANT, NEWBORN; LIPID METABOLISM; LIPOPROTEINS; MATERNAL-FETAL EXCHANGE; OBESITY; PREGNANCY; PREGNANCY IN DIABETICS; PREGNANCY OUTCOME;

EID: 84899059605     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1934     Document Type: Review

References (65)

1. Hernandez TL, Friedman JE, Van Pelt RE, Barbour LA. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care 2011;34:1660-1668
2. Middleton P, Crowther CA, Simmonds L. Different intensities of glycaemic control for pregnant women with pre-existing diabetes. Cochrane Database Syst Rev 2012;8:CD008540
3. Herrera E, Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy - Are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 2010;24:515-525
4. Gallos ID, Sivakumar K, Kilby MD, Coomarasamy A, Thangaratinam S, Vatish M. Pre-eclampsia is associated with, and preceded by, hypertriglyceridaemia: a meta-analysis. BJOG 2013;120:1321-1332
5. Vrijkotte TG, Krukziener N, Hutten BA, Vollebregt KC, van Eijsden M, Twickler MB. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J Clin Endocrinol Metab 2012;97:3917-3925
6. Mudd LM, Holzman CB, Catov JM, Senagore PK, Evans RW. Maternal lipids at mid-pregnancy and the risk of preterm delivery. Acta Obstet Gynecol Scand 2012;91:726-735
7. Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2010;89:700-704
8. Desoye G, Gauster M, Wadsack C. Placental transport in pregnancy pathologies. Am J Clin Nutr 2011;94(Suppl):1896S-1902S
9. Rebholz SL, Burke KT, Yang Q, Tso P, Woollett LA. Dietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta. Am J Physiol Endocrinol Metab 2011;301:E416-E425
10. Wender-Ozegowska E, Zawiejska A, Michalowska-Wender G, Iciek R, Wender M, Brazert J. Metabolic syndrome in type 1 diabetes mellitus. Does it have any impact on the course of pregnancy? J Physiol Pharmacol 2011;62:567-573
11. Biesenbach G, Janko O, Stöger H, Zazgornik J. Increases in serum lipids during pregnancy in type 1 diabetic women with nephropathy. Diabet Med 1994;11:262-267 (Pubitemid 24144141)
12. Merzouk H, Madani S, Korso N, Bouchenak M, Prost J, Belleville J. Maternal and fetal serum lipid and lipoprotein concentrations and compositions in type 1 diabetic pregnancy: relationship with maternal glycemic control. J Lab Clin Med 2000;136:441-448
13. Basu A, Alaupovic P, Wu M, et al. Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. J Clin Endocrinol Metab 2012;97:1752-1762
14. Montelongo A, Lasunción MA, Pallardo LF, Herrera E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 1992;41:1651-1659
15. Gobl CS, Handisurya A, Klein K, et al. Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects. Diabetes Care 2010;33:2071-2073
16. Toescu V, Nuttall SL, Martin U, et al. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci (Lond) 2004;106:93-98 (Pubitemid 38091344)
17. Sánchez-Vera I, Bonet B, Viana M, et al. Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metabolism 2007;56:1527-1533 (Pubitemid 47562503)
18. Rizzo M, Berneis K, Altinova AE, et al. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabet Med 2008;25:1406-1411
19. Marseille-Tremblay C, Ethier-Chiasson M, Forest J-C, et al. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev 2008;75:1054-1062 (Pubitemid 351628590)
20. Qiu C, Rudra C, Austin MA, Williams MA. Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size. Physiol Res 2007;56:571-578
21. Merzouk H, Meghelli-Bouchenak M, Loukidi B, Prost J, Belleville J. Impaired serum lipids and lipoproteins in fetal macrosomia related to maternal obesity. Biol Neonate 2000;77:17-24
22. Harmon KA, Gerard L, Jensen DR, et al. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth. Diabetes Care 2011;34:2198-2204
23. Savvidou M, Nelson SM, Makgoba M, Messow CM, Sattar N, Nicolaides K. First-trimester prediction of gestational diabetes mellitus: examining the potential of combining maternal characteristics and laboratory measures. Diabetes 2010;59:3017-3022
24. Kramer MS, Kahn SR, Rozen R, et al. Vasculopathic and thrombophilic risk factors for spontaneous preterm birth. Int J Epidemiol 2009;38:715-723
25. Edison RJ, Berg K, Remaley A, et al. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics 2007;120:723-733 (Pubitemid 47549559)
26. Barden A, Singh R, Walters BN, Ritchie J, Roberman B, Beilin LJ. Factors predisposing to pre-eclampsia in women with gestational diabetes. J Hypertens 2004;22:2371-2378
27. Kapoor N, Sankaran S, Hyer S, Shehata H. Diabetes in pregnancy: a review of current evidence. Curr Opin Obstet Gynecol 2007;19:586-590 (Pubitemid 350135443)
28. Schaefer-Graf UM, Graf K, Kulbacka I, et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008;31:1858-1863
29. Kehl RJ, Krew MA, Thomas A, Catalano PM. Fetal growth and body composition in infants of women with diabetes mellitus during pregnancy. J Matern Fetal Med 1996;5:273-280
30. Di Cianni G, Miccoli R, Volpe L, et al. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 2005;22:21-25 (Pubitemid 40188281)
31. Gasevic D, Frohlich J, Mancini GB, Lear SA. The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort. Metabolism 2012;61:583-589
32. Schreuder YJ, Hutten BA, van Eijsden M, et al. Ethnic differences in maternal total cholesterol and triglyceride levels during pregnancy: the contribution of demographics, behavioural factors and clinical characteristics. Eur J Clin Nutr 2011;65:580-589
33. Nolan CJ, Riley SF, Sheedy MT, Walstab JE, Beischer NA. Maternal serum triglyceride, glucose tolerance, and neonatal birth weight ratio in pregnancy. Diabetes Care 1995;18:1550-1556
34. Goldberg AS, Hegele RA. Severe hypertriglyceridemia in pregnancy. J Clin Endocrinol Metab 2012;97:2589-2596
35. Descamps OS, Bruniaux M, Guilmot PF, Tonglet R, Heller FR. Lipoprotein metabolism of pregnant women is associated with both their genetic polymorphisms and those of their newborn children. J Lipid Res 2005;46:2405-2414 (Pubitemid 41532528)
36. Rees K, Dyakova M, Ward K, Thorogood M, Brunner E. Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev 28 March 2013:CD002128
37. Aucott L, Gray D, Rothnie H, Thapa M, Waweru C. Effects of lifestyle interventions and long-term weight loss on lipid outcomes - a systematic review. Obes Rev 2011;12:e412-e425
38. Khoury J, Henriksen T, Christophersen B, Tonstad S. Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial. Am J Obstet Gynecol 2005;193:1292-1301 (Pubitemid 41395095)
39. Knopp RH, Magee MS, Raisys V, Benedetti T, Bonet B. Hypocaloric diets and ketogenesis in the management of obese gestational diabetic women. J Am Coll Nutr 1991;10:649-667
40. Nolan CJ. Improved glucose tolerance in gestational diabetic women on a low fat, high unrefined carbohydrate diet. Aust N Z J Obstet Gynaecol 1984;24:174-177 (Pubitemid 14024324)
41. Rhodes ET, Pawlak DB, Takoudes TC, et al. Effects of a low-glycemic load diet in overweight and obese pregnant women: a pilot randomized controlled trial. Am J Clin Nutr 2010;92:1306-1315
42. Hopkins SA, Baldi JC, Cutfield WS, McCowan L, Hofman PL. Effects of exercise training on maternal hormonal changes in pregnancy. Clin Endocrinol (Oxf) 2011;74:495-500
43. Hollingsworth DR, Moore TR. Postprandial walking exercise in pregnant insulin-dependent (type I) diabetic women: reduction of plasma lipid levels but absence of a significant effect on glycemic control. Am J Obstet Gynecol 1987;157:1359-1363 (Pubitemid 18022857)
44. Hague WM, Davoren PM, McIntyre HD, Norris R, Xiaonian X, Charles BG. Metformin crosses the placenta: a modulator for fetal insulin resistance? [article online], 2003. Available from http://www.bmj.com/rapid-response/2011/ 10/30/metformin-crosses-placenta-modulator-fetal-insulin-resistance. Accessed 23 February 2014
45. Barrett HL, Gatford KL, Houda CM, et al. Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatment. Diabetes Care 2013;36:529-536
46. Lindström T, Arnqvist HJ, Olsson AG. Effect of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1990;81:137-144 (Pubitemid 20098744)
47. Bays H. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians. Drugs Today 2008;44:205-246
48. Szajewska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with low-risk pregnancies on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2006;83:1337-1344 (Pubitemid 44713064)
49. Zhou SJ, Yelland L, McPhee AJ, Quinlivan J, Gibson RA, Makrides M. Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsia. Am J Clin Nutr 2012;95:1378-1384
50. Muhlhausler BS, Gibson RA, Makrides M. Effect of long-chain polyunsaturated fatty acid supplementation during pregnancy or lactation on infant and child body composition: a systematic review. Am J Clin Nutr 2010;92:857-863
51. Kusters DM, Lahsinoui HH, van de Post JA, et al. Statin use during pregnancy: a systematic review and meta-analysis. Expert Rev Cardiovasc Ther 2012;10:363-378
52. Lecarpentier E, Morel O, Fournier T, Elefant E, Chavatte-Palmer P, Tsatsaris V. Statins and pregnancy: between supposed risks and theoretical benefits. Drugs 2012;72:773-788
53. Statins to ameliorate early onset preeclampsia [article online], 2013. Available from http://www.controlled-trials.com/ISRCTN23410175. Accessed 21 January 2013
54. Costantine MM, Cleary K; Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric-Fetal Pharmacology Research Units Network. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol 2013;121:349-353
55. Kei A, Elisaf MS. Nicotinic acid: clinical considerations. Expert Opin Drug Saf 2012;11:551-564
56. Cottart CH, Nivet-Antoine V, Beaudeux JL. Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans. Mol Nutr Food Res 2014;58:7-21
57. Singh CK, Kumar A, Lavoie HA, Dipette DJ, Singh US. Diabetic complications in pregnancy: is resveratrol a solution? Exp Biol Med (Maywood) 2013;238:482-490
58. Gil-Sánchez A, Demmelmair H, Parrilla JJ, Koletzko B, Larqué E. Mechanisms involved in the selective transfer of long chain polyunsaturated Fatty acids to the fetus. Front Genet 2011;2:57
59. Woollett LA. Review: transport of maternal cholesterol to the fetal circulation. Placenta 2011;32(Suppl. 2):S218-S221
60. Cetin I, Parisi F, Berti C, Mando C, Desoye G. Placental fatty acid transport in maternal obesity. J Dev Orig of Health Dis 2012;3:409-414
61. Lippi G, Albiero A, Montagnana M, et al. Lipid and lipoprotein profile in physiological pregnancy. Clin Lab 2007;53:173-177 (Pubitemid 46656573)
62. Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med 2011;28:1053-1059
63. Szymanska M, Bomba-Opon DA, Wielgos M. Blood pressure and lipid changes in gestational diabetes mellitus. Neuroendocrinol Lett 2008;29:328-333
64. Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ. Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care 1992;15:1605-1613
65. Clark CM Jr, Qiu C, Amerman B, et al. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care 1997;20:867-871 (Pubitemid 27202544)